Community lists
精选 · 医疗保健

Big pharma

由 InspectStocks 整理Published 2026年10月14日13 companies0 followers

The largest drugmakers, selling prescription medicines worldwide.

借助 AI 模型分组,并经我们的编辑审核。每家公司下方的一行说明它为何在这里。

A
  • LLYELI Lilly
    US$1,437.79+42.2% 1Y

    Sells prescription medicines for diabetes, obesity, cancer and inflammation

  • JNJJohnson & Johnson
    US$280.34+47.5% 1Y

    Sells prescription medicines for cancer and immune disorders

  • MRKMerck
    US$147.20+65.7% 1Y

    Sells prescription medicines and vaccines for people and animals

  • NVSNovartis
    US$160.36+23.6% 1Y

    Sells prescription medicines

  • AMGNAmgen
    US$468.13+43.1% 1Y

    Develops and sells medicines and biosimilars for serious diseases

  • GSKGSK
    US$50.60+8.9% 1Y

    Sells prescription medicines and vaccines worldwide

  • TAKTakeda Pharmaceutical
    US$20.86+50.1% 1Y

    Sells prescription medicines and vaccines globally

B
  • ABBVAbbVie
    US$294.87+30.2% 1Y

    Sells medicines for immune, neurological and cancer conditions

  • AZN因增长减弱下调一级Astrazeneca
    US$185.49+115.2% 1Y

    Sells prescription medicines

  • SNYSanofi
    US$48.43-3.0% 1Y

    Sells prescription medicines and vaccines

C
  • NVONovo Nordisk A/S
    US$41.10-15.4% 1Y

    Sells diabetes and obesity medicines

  • PFE因增长减弱下调一级Pfizer
    US$29.45+21.4% 1Y

    Sells prescription medicines and vaccines

  • BMYBristol-Myers Squibb
    US$62.92+34.0% 1Y

    Sells prescription medicines for cancer and immune conditions

D

这里没有公司处于这一评级。

F

这里没有公司处于这一评级。

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.